For the Inventor, By the Inventor

Enter assignee name

Milwaukee, WI, United States of America

Mcw Research Foundation, Inc.

USPTO Granted Patents = 61

% Expired Patents = 29.5

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 926

Loading Chart...

Loading Chart...

102 inventors (with patents filed for the assignee):

James Stewart Hyde (10 out of 24 patents)

Andrzej Jesmanowicz (8 out of 12 patents)

Richard J Roman (6 out of 9 patents)

4. John L Ulmer (4 out of 4 patents)

5. David R Harder (4 out of 6 patents)

6. Wojciech Froncisz (4 out of 12 patents)

7. Ching-San Lai (4 out of 30 patents)

8. Balaraman Kalyanaraman (3 out of 16 patents)

9. Dara W Frank (3 out of 5 patents)

10. Joseph T Barbieri (3 out of 9 patents)

11. Edgar A DeYoe (3 out of 3 patents)

12. Kathleen M Schmainda (3 out of 4 patents)

13. Magdalena Alonso-Galicia (3 out of 3 patents)

14. Elizabeth R Jacobs (3 out of 3 patents)

15. John Russell Falck (3 out of 34 patents)

Core Competencies:

MRI Techniques

NMR Signal Digitization

Tumor Diagnostics

Cell Adhesion

Thrombopoietin Receptor

Cardiac Hypertrophy

Nitric Oxide Reduction

Vascular Disease

Photobiomodulation

Natural Killer Cells

Gene Detection

Electron Paramagnetic Resonance

61 patents: Sort by Forward Citations

1. 8518883 - Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand (2013-08-27),

2. 8404640 - Method of diagnosing and treating colon cancer (2013-03-26),

3. 8388936 - In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging (2013-03-05),

4. 8101347 - [object Object] (2012-01-24),

5. 8021892 - System and method for direct digitization of NMR signals (2011-09-20),

6. 7943631 - Method of treating drug addiction using dextro-morphine (2011-05-17),

7. 7939326 - Methods and compositions for enhancing cell adhesion properties (2011-05-10),

8. 7879318 - Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand (2011-02-01),

9. 7867496 - Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents (2011-01-11),

10. 7838561 - Method for preventing or treating cardiac hypertrophy (2010-11-23),

11. 7807474 - System and method for direct digitization of NMR signals (2010-10-05),

12. 7788075 - System and method for sensory defect simulation (2010-08-31),

13. 7603240 - Peptide identification (2009-10-13),

14. 7577472 - MRI method for producing an index indicative of brain disorders (2009-08-18),

15. 7567832 - MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation (2009-07-28),

Company Overview

Mcw Research Foundation, Inc., based in Milwaukee, WI, specializes in advancing medical imaging technologies with a focus on MRI techniques and NMR signal digitization. The foundation is dedicated to enhancing tumor diagnostics and exploring critical areas such as cell adhesion and thrombopoietin receptor research. Its work also encompasses the study of cardiac hypertrophy, nitric oxide reduction, and vascular disease, contributing to significant advancements in medical science and patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

61 Patents

#35 in Milwaukee, WI

#150 in Wisconsin

#5,914 in US

#11,923 in the World

Milwaukee, WI, United States of America

Mcw Research Foundation, Inc.

Forward Citations = 926

102 inventors:

James Stewart Hyde (10 out of 24 patents)

Andrzej Jesmanowicz (8 out of 12 patents)

Richard J Roman (6 out of 9 patents)

4. John L Ulmer (4 out of 4 patents)

5. David R Harder (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mcw Research Foundation, Inc.. Retrieved from https://idiyas.com/company/mcw-research-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…